Keyphrases
Chronic Heart Failure
53%
Placebo
53%
Heart Failure
48%
Angiotensin II (Ang II)
46%
Aldosterone
43%
Angiotensin-converting Enzyme Inhibitor (ACEi)
39%
Allopurinol
33%
B-type Natriuretic Peptide
33%
Blood Pressure
31%
Left Ventricular Hypertrophy
30%
Spironolactone
30%
Randomized Controlled Trial
28%
Atrial Natriuretic Peptide
24%
Atrial Natriuretic Factor
23%
Heart Failure Patients
22%
Endothelial Function
20%
Left Ventricular Systolic Dysfunction
18%
Left Ventricular Mass
18%
Patients with Heart Failure
18%
Brain Natriuretic Peptide
18%
Patients with Chronic Heart Failure
17%
QT Dispersion
16%
Older People
16%
Type 2 Diabetes Mellitus (T2DM)
15%
Hypertension
15%
Captopril
15%
Endothelial Dysfunction
14%
Angiotensin-converting Enzyme
14%
High Dose
14%
Echocardiography
13%
Cardiovascular Disease
13%
Confidence Interval
13%
Sarcopenia
13%
Coronary Artery Disease
13%
Heart Rate
13%
Aldosterone Blockade
12%
Renin-angiotensin-aldosterone System
12%
Natriuretic Peptides
12%
Myocardial Infarction
12%
Noradrenaline
12%
Systolic Blood Pressure
12%
Cardiovascular Risk
11%
Beta-blockers
11%
Type 2 Diabetic Patients
11%
Randomized Placebo-controlled Trial
11%
Physical Function
11%
Whole-body
11%
Diuretics
11%
Left Ventricular Dysfunction
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Placebo
53%
Aldosterone
40%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Angiotensin II
35%
Brain Natriuretic Peptide
33%
Allopurinol
31%
Atrial Natriuretic Factor
28%
Spironolactone
25%
Renin
24%
Dipeptidyl Carboxypeptidase
21%
Noradrenalin
20%
Heart Left Ventricle Hypertrophy
18%
Angiotensin
17%
Randomized Controlled Trial
16%
Non Insulin Dependent Diabetes Mellitus
16%
Captopril
15%
Diabetes Mellitus
14%
Endothelial Dysfunction
13%
Coronary Artery Disease
13%
Heart Infarction
13%
Natriuretic Factor
12%
Cardiovascular Disease
12%
Epinephrine
11%
Normal Human
11%
Isotopes of Potassium
10%
Acute Heart Infarction
9%
Vitamin D
8%
Enalapril
8%
Furosemide
8%
Nitric Oxide
8%
Heart Left Ventricle Failure
7%
Diuretic Agent
7%
Angiotensin I
7%
Left Ventricular Systolic Dysfunction
7%
Beta Adrenergic Receptor Blocking Agent
7%
Angiotensin Receptor Antagonist
7%
Ciclosporin
6%
Cerebrovascular Accident
6%
Acetylcholine
6%
Cohort Study
6%
Ischemic Heart Disease
6%
Salbutamol
6%
Cardiovascular Risk
6%
Enzyme Inhibition
6%
Urate
6%
Hypokalemia
6%
Metformin
5%
Losartan
5%
Sarcopenia
5%
Medicine and Dentistry
Congestive Heart Failure
80%
Brain Natriuretic Peptide
40%
Placebo
37%
Aldosterone
30%
Randomized Controlled Trial
26%
ACE Inhibitor
25%
Blood Pressure
23%
Left Ventricular Hypertrophy
22%
Angiotensin II
19%
Cardiovascular System
17%
Allopurinol
15%
Atrial Natriuretic Factor
15%
Left Ventricular Systolic Dysfunction
15%
Cardiovascular Disease
15%
Endothelial Function
15%
Coronary Artery Disease
14%
Echocardiography
13%
Spironolactone
12%
Apoplexy
11%
Diabetes Mellitus
11%
Cardiac Magnetic Resonance Imaging
10%
Sarcopenia
10%
Arterial Stiffness
10%
Chronic Obstructive Pulmonary Disease
10%
Vitamin D
9%
Maturity Onset Diabetes of the Young
9%
Perindopril
9%
Natriuretic Factor
9%
Electrocardiogram
9%
Heart Death
8%
Volunteer
8%
Exercise
8%
Physical Performance
8%
Endothelial Dysfunction
8%
Cardiovascular Risk
8%
QT Dispersion
8%
Cyclosporine
8%
Supplementation
7%
Dipeptidyl Carboxypeptidase
7%
Diuretic Agent
7%
Infusion
7%
Myocardial Infarction
7%
Quality of Life
7%
Systolic Blood Pressure
7%
Noradrenalin
7%
Prevalence
7%
Ischemic Heart Disease
7%
Patient with Type 2 Diabetes
6%
Meta-Analysis
6%
Diabetes
6%